Stay updated on Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Sign up to get notified when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page now indicates recruitment has closed and introduces new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study); the Intervention/Treatment heading formatting and the site version have been updated from v3.5.5 to v3.6.0.
    Difference
    0.2%
    Check dated 2026-06-15T21:58:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision tag v3.5.5 was added and the previous v3.5.4 tag was removed. This indicates a minor update to the page's version metadata.
    Difference
    0.0%
    Check dated 2026-06-08T17:22:15.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new platform release or patch rather than a change to the study data.
    Difference
    0.0%
    Check dated 2026-05-18T03:59:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page revision label has been updated from v3.5.2 to v3.5.3. This reflects a site/version metadata refresh rather than a change to the clinical study information presented.
    Difference
    0.0%
    Check dated 2026-04-26T08:22:53.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T01:38:02.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added new trial sites: Wrocław, Poland (51-685) and Lviv, Ukraine (79029), and added the collaborator 'Neurofocus LLC'. Removed outdated site entries for Wroclaw (51-685), Lviv in Chernihiv Governorate (79007), and the MNE Lviv Territorial Medical Association Clinical Hospital for Palliative Care.
    Difference
    0.3%
    Check dated 2026-03-28T13:52:34.000Z thumbnail image

Stay in the know with updates to Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Fenebrutinib vs Ocrelizumab in Primary Progressive MS Clinical Trial page.